Professor Jackie Hunter

  • CEO
    OIPharma Partners Ltd
  • Chairman
    Boards of Biocortex Ltd
    Brainomix and Stevenage Bioscience Catalyst

Jackie Hunter has had an extensive career in the Pharmaceutical industry including Senior Vice-President of Neurology and Gastrointestinal Centre of Excellence for GlaxoSmithKline. She was Chief Executive of the Biotechnology and Biological Sciences Research Council (BBSRC), one of the then seven Research Councils in the UK, from 2013 to 2016 and subsequently became Chief Executive of BenevolentBio Ltd, establishing it as the Pharmaceutical R&D arm of BenevolentAI, a company using Artificial Intelligence (AI) to accelerate pharmaceutical R&D. In 2020 she left her executive role at BenevolentAI but she remains a board director of the company.

She has had a number of non-executive director roles in both public and private companies and is currently Chair of the Boards of Brainomix, an AI-driven imaging company and the Stevenage Bioscience Catalyst. She is also a Director of the UK BioIndustry Association and is Chair of the Trustees of the Sainsbury Laboratory, Norwich, which focusses on plant disease.

She was Chair of the Research Chair of Research Directors' Group, European Federation of Pharmaceutical Industry Associations and an Innovative Medicines Initiative Board member and has served on numerous panels and advisory boards for industry, government and academia. Currently, she is a member of the technology advisory board for BP plc, the Science Advisory Board of the Data Science Institute, Imperial College, London and a Member of Royal Society Science, Industry and Translation Committee and Deputy Chair Industry Fellowship awards panel.

She has received a number of awards and honorary doctorates as well as a CBE for services to the Pharmaceutical Industry in 2010. She is a Fellow of the Academy of Medical Sciences, The Royal Society of Biology, The Zoological Society of London and an Honorary Fellow of the British Pharmacological Society.